Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL37A divergent transcript (RPL37A-DT) is a human long non-coding RNA (lncRNA) gene located near the coding gene RPL37A. It does not encode a protein and its biological function is not currently established. The locus has no known Mendelian phenotype association and is not reported as a receptor, enzyme, transporter, or other classical drug target. As a divergent transcript, it is classified as a non-coding RNA, and may have regulatory functions typical of lncRNAs, but specific roles in health or disease have not been characterized. RPL37A-DT must be distinguished from RPL37A, a protein-coding gene encoding a ribosomal protein, which does have known biological roles and disease associations. RPL37A-DT is confirmed as a distinct gene with the type "ncRNA (non-coding RNA)" in gene databases and has no known involvement as a primary target for therapeutics or as a disease biomarker. No common aliases or substantial functional/mechanistic information is currently available, reflecting the limited understanding of this lncRNA in biomedical literature.
Not applicable; no known drug interactions or therapeutic mechanism established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL37A divergent transcript (RPL37A-DT).